Company Filing History:
Years Active: 1998-2011
Title: The Innovative Contributions of Amy H. Yin
Introduction
Amy H. Yin is a prominent inventor based in San Jose, California. She has made significant contributions to the field of hematopoietic stem cell research. With a total of three patents to her name, her work has advanced the understanding and application of stem cell technology.
Latest Patents
Amy H. Yin's latest patents include groundbreaking compositions that involve a cell expressing the AC133 cell surface antigen. These compositions provide antibodies or antigen-binding fragments that specifically bind to the AC133 antigen. The expression of this antigen is highly tissue-specific and is detected on a subset of hematopoietic progenitor and stem cells derived from various sources, including human bone marrow, fetal bone marrow, liver, cord blood, and adult peripheral blood. The cells recognized by AC133 are CD34 positive and contain substantially all of the CFU-GM activity present in the CD34 population. This specific distribution makes AC133 exceptionally useful for isolating and characterizing human hematopoietic progenitor and stem cells.
Career Highlights
Amy H. Yin is currently associated with Amcell Corporation, where she continues her innovative work in stem cell research. Her contributions have been pivotal in advancing the field and enhancing the understanding of hematopoietic stem cells.
Collaborations
Some of her notable coworkers include Sheri Miraglia and David W. Buck. Their collaborative efforts have further enriched the research environment and fostered innovation in their projects.
Conclusion
Amy H. Yin's work exemplifies the impact of innovative research in the field of hematopoietic stem cells. Her patents and collaborations highlight her commitment to advancing scientific knowledge and technology.